OrbiMed’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-4,806,900
| Closed | -$73.1M | – | 161 |
|
|
2018
Q3 | $73.1M | Sell |
4,806,900
-94,000
| -2% | -$1.44M | 0.88% | 34 |
|
|
2018
Q2 | $82.2M | Hold |
4,900,900
| – | – | 0.98% | 34 |
|
|
2018
Q1 | $80M | Sell |
4,900,900
-2,720,500
| -36% | -$43.6M | 0.99% | 34 |
|
|
2017
Q4 | $97.6M | Sell |
7,621,400
-6,561,500
| -46% | -$74.6M | 1.23% | 24 |
|
|
2017
Q3 | $174M | Hold |
14,182,900
| – | – | 1.67% | 19 |
|
|
2017
Q2 | $119M | Hold |
14,182,900
| – | – | 1.24% | 24 |
|
|
2017
Q1 | $127M | Sell |
14,182,900
-1,905,900
| -12% | -$20.3M | 1.44% | 21 |
|
|
2016
Q4 | $141M | Buy |
16,088,800
+1,908,900
| +13% | +$14M | 1.8% | 19 |
|
|
2016
Q3 | $95.7M | Buy |
14,179,900
+3,206,000
| +29% | +$12.4M | 1.09% | 32 |
|
|
2016
Q2 | $39.1M | Buy |
10,973,900
+284,900
| +3% | +$928K | 0.41% | 58 |
|
|
2016
Q1 | $31.5M | Hold |
10,689,000
| – | – | 0.33% | 58 |
|
|
2015
Q4 | $45.1M | Buy |
10,689,000
+628,500
| +6% | +$2.87M | 0.41% | 55 |
|
|
2015
Q3 | $45.9M | Hold |
10,060,500
| – | – | 0.46% | 47 |
|
|
2015
Q2 | $72.5M | Buy |
10,060,500
+828,190
| +9% | +$6.11M | 0.61% | 48 |
|
|
2015
Q1 | $68M | Buy |
9,232,310
+1,984,610
| +27% | +$14.1M | 0.58% | 47 |
|
|
2014
Q4 | $34.3M | Buy |
7,247,700
+844,900
| +13% | +$3.34M | 0.33% | 63 |
|
|
2014
Q3 | $22.9M | Hold |
6,402,800
| – | – | 0.24% | 70 |
|
|
2014
Q2 | $29.2M | Buy |
6,402,800
+105,800
| +2% | +$438K | 0.34% | 55 |
|
|
2014
Q1 | $29.6M | Buy |
6,297,000
+972,000
| +18% | +$4.89M | 0.36% | 51 |
|
|
2013
Q4 | $26.7M | Buy |
5,325,000
+493,400
| +10% | +$2.69M | 0.39% | 55 |
|
|
2013
Q3 | $30.1M | Sell |
4,831,600
-33,400
| -0.7% | -$198K | 0.54% | 44 |
|
|
2013
Q2 | $22.1M | Buy |
+4,865,000
| New | +$26.2M | 0.47% | 43 |
|
Other funds holding ARRY
RG
FCM
BBA